相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。N-acetylcysteine in preclinical mouse and baboon models of thrombotic thrombocytopenic purpura
Claudia Tersteeg et al.
BLOOD (2017)
A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von willebrand factor
Kieron South et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity: comment
W. J. Cao et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity: reply
K. South et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease
Frederik Denorme et al.
PLOS ONE (2017)
Thrombotic thrombocytopenic purpura
Johanna A. Kremer Hovinga et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura
Marie Scully et al.
BLOOD (2017)
Von Willebrand Factor, ADAMTS13, and the Risk of Mortality The Rotterdam Study
Michelle A. H. Sonneveld et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Acquired von Willebrand syndrome associated with left ventricular assist device
Angelo Nascimbene et al.
BLOOD (2016)
N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance
Alain Chion et al.
BLOOD (2016)
N-linked glycan stabilization of the VWF A2 domain
Christopher J. Lynch et al.
BLOOD (2016)
CD4+ T cells from patients with acquired thrombotic thrombocytopenic purpura recognize CUB2 domain-derived peptides
Fabian C. Verbij et al.
BLOOD (2016)
Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: a potential link of inflammation to TTP
Vikram G. Pillai et al.
BLOOD (2016)
ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in mice
Frederik Denorme et al.
BLOOD (2016)
The role of ADAMTS13 in acute myocardial infarction: cause or consequence?
Elise S. Eerenberg et al.
CARDIOVASCULAR RESEARCH (2016)
Update on ADAMTS13 and VWF in cardiovascular and hematological disorders
Omer Akyol et al.
CLINICA CHIMICA ACTA (2016)
Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity
K. South et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
Flora Peyvandi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Force sensing by the vascular protein von Willebrand factor is tuned by a strong intermonomer interaction
Jochen P. Mueller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Thromboinflammation in Stroke Brain Damage
Simon F. De Meyer et al.
STROKE (2016)
Generation of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura
Louis Deforche et al.
PLOS ONE (2016)
Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic Purpura
Claudia Tersteeg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis
Rens de Groot et al.
BLOOD (2015)
Low ADAMTS13 activity is associated with an increased risk of ischemic stroke
M. A. H. Sonneveld et al.
BLOOD (2015)
Delayed treatment with ADAMTS13 ameliorates cerebral ischemic injury without hemorrhagic complication
Takafumi Nakano et al.
BRAIN RESEARCH (2015)
ADAMTS13 and von Willebrand factor interactions
Catherine B. Zander et al.
CURRENT OPINION IN HEMATOLOGY (2015)
Acquired thrombotic thrombocytopenic purpura: new therapeutic options and their optimal use
S. R. Cataland et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13
L. Deforche et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Plasma ADAMTS-13 levels and the risk of myocardial infarction: an individual patient data meta-analysis
A. Maino et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Probing ADAMTS13 Substrate Specificity using Phage Display
Karl C. Desch et al.
PLOS ONE (2015)
Massively parallel enzyme kinetics reveals the substrate recognition landscape of the metalloprotease ADAMTS13
Colin A. Kretz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome Results of the ATHEROREMO-IVUS study
Michelle A. H. Sonneveld et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura
Mari R. Thomas et al.
EBIOMEDICINE (2015)
Control of VWF A2 domain stability and ADAMTS13 access to the scissile bond of full-length VWF
Christopher J. Lynch et al.
BLOOD (2014)
How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Plasmin Cleavage of von Willebrand Factor Emergency Bypass for ADAMTS13 Deficiency in Thrombotic Microangiopathy
Claudia Tersteeg et al.
CIRCULATION (2014)
Anti-ADAMTS13 IgG autoantibodies present in healthy individuals share linear epitopes with those in patients with thrombotic thrombocytopenic purpura
Rana Grillberger et al.
HAEMATOLOGICA (2014)
ADAMTS13 modulates atherosclerotic plaque progression in mice via a VWF-dependent mechanism
C. Gandhi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Allosteric activation of ADAMTS13 by von Willebrand factor
Joshua Muia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Conformational activation of ADAMTS13
Kieron South et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice
Lixiang Wang et al.
ANNALS OF NEUROLOGY (2013)
Relationship of Von Willebrand Factor with carotid artery and aortic arch calcification in ischemic stroke patients
Michelle A. H. Sonneveld et al.
ATHEROSCLEROSIS (2013)
Unwinding the von Willebrand factor strings puzzle
Karen De Ceunynck et al.
BLOOD (2013)
Mechanisms by which von Willebrand Disease Mutations Destabilize the A2 Domain
Amy J. Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Crystal structure and enzymatic activity of an ADAMTS-13 mutant with the East Asian-specific P475S polymorphism
M. Akiyama et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Structure-function and regulation of ADAMTS-13 protease
X. L. Zheng
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women
Helena M. Andersson et al.
BLOOD (2012)
A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13
Alexandra Schiviz et al.
BLOOD (2012)
Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage
Paula M. Jacobi et al.
BLOOD (2012)
Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura
Cui Jian et al.
BLOOD (2012)
Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice
Simon F. De Meyer et al.
BLOOD (2012)
ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia/reperfusion injury in mice
Chintan Gandhi et al.
BLOOD (2012)
Sequence and structure relationships within von Willebrand factorSequence and structure relationships within von Willebrand factor
Yan-Feng Zhou et al.
BLOOD (2012)
Macrophage LRP1 contributes to the clearance of von Willebrand factor
Ghasem Rastegarlari et al.
BLOOD (2012)
Shear stress is required for the endocytic uptake of the factor VIII-von Willebrand factor complex by macrophages
L. Castro-Nunez et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
von Willebrand Factor An Emerging Target in Stroke Therapy
Simon F. De Meyer et al.
STROKE (2012)
Essential Domains of A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13 Metalloprotease Required for Modulation of Arterial Thrombosis
Juan Xiao et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor
James T. B. Crawley et al.
BLOOD (2011)
Local Elongation of Endothelial Cell-anchored von Willebrand Factor Strings Precedes ADAMTS13 Protein-mediated Proteolysis
Karen De Ceunynck et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13)
Yaozu Xiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura
Petra Jilina-Stohlawetz et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Calcium modulates force sensing by the von Willebrand factor A2 domain
Arjen J. Jakobi et al.
NATURE COMMUNICATIONS (2011)
Unfolding the A2 Domain of Von Willebrand Factor with the Optical Trap
Junyi Ying et al.
BIOPHYSICAL JOURNAL (2010)
An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF
Wouter Pos et al.
BLOOD (2010)
Force-induced cleavage of single VWF A1A2A3 tridomains by ADAMTS-13
Tao Wu et al.
BLOOD (2010)
Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus)
Hendrik B. Feys et al.
BLOOD (2010)
Amino acid residues Arg659, Arg660, and Tyr661 in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor
Sheng-Yu Jin et al.
BLOOD (2010)
The importance of vicinal cysteines, C1669 and C1670, for von Willebrand factor A2 domain function
Brenda M. Luken et al.
BLOOD (2010)
Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients
T. N. Bongers et al.
ATHEROSCLEROSIS (2009)
A functional calcium-binding site in the metalloprotease domain of ADAMTS13
Michelle D. Gardner et al.
BLOOD (2009)
vonWillebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke
Bing-Qiao Zhao et al.
BLOOD (2009)
A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF
Sara Zanardelli et al.
BLOOD (2009)
VH1-69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura
W. Pos et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Multi-step binding of ADAMTS-13 to von Willebrand factor
H. B. Feys et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor
Qing Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand Factor
Xiaohui Zhang et al.
SCIENCE (2009)
Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity
Weiqiang Gao et al.
BLOOD (2008)
N-linked glycosylation of VWF modulates its interaction with ADAMTS13
Thomas A. J. McKinnon et al.
BLOOD (2008)
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura
J. Evan Sadler
BLOOD (2008)
Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack
J. T. B. Crawley et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease
Weiqiang Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Characterization of a core binding site for ADAMTS-13 in the A2 domain of von Willebrand factor
Jing-Jiang Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
High von Willebrand factor levels increase the risk of first ischemic stroke -: Influence of ADAMTS13, inflammation, and genetic variability
Tamara N. Bongers et al.
STROKE (2006)
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
J. E. Sadler et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Impact of mutations in the von Willebrand factor A2 domain on ADAMTS 13-dependent proteolysis
WA Hassenpflug et al.
BLOOD (2006)
Zinc and calcium ions cooperatively modulate ADAMTS13 activity
PJ Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Crystal structure of the TSP-1 type 1 repeats: a novel layered fold and its biological implication
KM Tan et al.
JOURNAL OF CELL BIOLOGY (2002)
Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura
XL Zheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
GG Levy et al.
NATURE (2001)
A novel human metalloprotease synthesized in the liver and secreted into the blood: Possibly, the von Willebrand factor-cleaving protease?
K Soejima et al.
JOURNAL OF BIOCHEMISTRY (2001)
Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family
K Fujikawa et al.
BLOOD (2001)
Partial amino acid sequence of purified von Willebrand factor-cleaving protease
HE Gerritsen et al.
BLOOD (2001)
分享论文
